• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke
We report clinical, laboratory, imaging findings and treatment in a 51-year-old female presenting with acute left middle cerebral artery (MCA) occlusion 7 days after the first dose of ChAdOx1 nCoV-19 vaccine.
Source: Journal of Stroke and Cerebrovascular Diseases - August 28, 2021 Category: Neurology Authors: Jana Kenda, Dimitrij Lovri č, Matevž Škerget, Nataša Milivojević Tags: Short Communication Source Type: research

Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 – Systematic Review, Meta-analysis, and Meta-regression
At the time of writing this paper, Coronavirus Disease 2019 (COVID-19) was announced as a global pandemic which has infected over 3.3 million people and cause more than 238.000 deaths,1 these numbers are likely to increase by the time of publication. Even though most of the infected individuals have mild or no symptoms, some of them exhibit more serious complications, including severe pneumonia, acute respiratory distress syndrome, and multi-organ failure. Clinical markers can be valuable for efficient allocation of resources during a pandemic.
Source: Journal of Stroke and Cerebrovascular Diseases - May 13, 2020 Category: Neurology Authors: Raymond Pranata, Ian Huang, Michael Anthonius Lim, Prof. Eka Julianta Wahjoepramono, Julius July Source Type: research

The interplay between COVID 19 and non-communicable diseases
Since the coronavirus designated as COVID-19 emerged as a global pathogen in late 2019, there has been rapid spread across the globe. After originating in China, several high-income countries such as Italy, Spain, United States, and the United Kingdom have had high case prevalence and high levels of mortality.
Source: Journal of Stroke and Cerebrovascular Diseases - June 30, 2020 Category: Neurology Authors: Seemant Chaturvedi, Philip Gorelick Source Type: research

In defense of our patients: indirect negative neurological consequences of sars-cov-2 in the new york epicenter
New York has become the epicenter in the United States for the coronavirus disease 2019 (COVID-19) pandemic with approximately 202,829 infected, 52,697 hospitalized, and 17,055 confirmed deaths as of June 5, 2020.15 The large influx of critically ill patients resulted in widespread policy and practice changes to counter this new resource-limited setting. All elective surgeries were cancelled. Urgent cases required approval and were limited significantly, resulting in primarily emergency cases.
Source: Journal of Stroke and Cerebrovascular Diseases - July 9, 2020 Category: Neurology Authors: Jared B. Cooper, Anubhav G. Amin, Michael G. Kim, Alan A. Stein, Jose Dominguez, Krishna Amuluru, Rachana Tyagi, Stephan Mayer, Chirag D. Gandhi, Fawaz Al-Mufti Source Type: research

Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 –systematic review, meta-analysis, and meta-regression
At the time of writing this paper, Coronavirus Disease 2019 (COVID-19) was declared a global pandemic, which had infected over 3.3 million people and caused more than 238.000 deaths,1 These numbers are likely to increase by the time of publication. Even though most of the infected individuals have mild or no symptoms, some exhibit more serious complications including severe pneumonia, acute respiratory distress syndrome, and multi-organ failure. Clinical markers can be valuable for the efficient allocation of resources during the pandemic.
Source: Journal of Stroke and Cerebrovascular Diseases - May 13, 2020 Category: Neurology Authors: Raymond Pranata, Ian Huang, Michael Anthonius Lim, Eka Julianta Wahjoepramono, Julius July Source Type: research

Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis
We appreciate Klein et al. [1] for reporting the case of cerebral venous thrombosis accompanied by hemorrhagic infarct in a young patient with novel coronavirus disease 2019 (COVID-19). The reporting of such a case would raise the awareness of the possibility of the occurrence of cerebral venous thrombosis in the course of COVID-19, especially among the young adults present with COVID-19 and neurological symptoms.
Source: Journal of Stroke and Cerebrovascular Diseases - August 2, 2020 Category: Neurology Authors: Chia Siang Kow, Abdullah Faiz Zaihan, Syed Shahzad Hasan Source Type: research

The association of cerebrovascular disease with adverse outcomes in COVID-19 patients: a meta-analysis based on adjusted effect estimates
The aim of this study was to address the association between cerebrovascular disease and adverse outcomes in coronavirus disease 2019 (COVID-19) patients by using a quantitative meta-analysis based on adjusted effect estimates.
Source: Journal of Stroke and Cerebrovascular Diseases - August 27, 2020 Category: Neurology Authors: Jie Xu, Wenwei Xiao, Xuan Liang, Peihua Zhang, Li Shi, Ying Wang, Yadong Wang, Haiyan Yang Source Type: research

Cerebral Microhemorrhage and Purpuric Rash in COVID-19: The Case for a Secondary Microangiopathy
We report the case of a COVID-19 patient with diffuse microhemorrhages on brain MRI, positive anticardiolipin antibodies, and purpuric rash with biopsy showing a thrombotic vasculopathy, all features suggestive of secondary microangiopathy.
Source: Journal of Stroke and Cerebrovascular Diseases - August 11, 2020 Category: Neurology Authors: Aaron Shoskes, Ibrahim Migdady, Anthony Fernandez, Paul Ruggieri, Alexander Rae-Grant Tags: Case Report Source Type: research

Postpartum Atypical Posterior Reversible Encephalopathy Syndrome in a COVID-19 patient- An Obstetric Emergency
Encephalopathy in COVID-19 has been widely reported with several reports of posterior reversible encephalopathy syndrome (PRES) speculated to be due to an abrupt surge in blood pressure caused by coronavirus disease. Though peripartum posterior reversible encephalopathy syndrome is well recognized, its atypical variant with hemorrhage is uncommon. Peripartum atypical posterior reversible encephalopathy syndrome with COVID-19 requires early recognition and warrants dedicated inter-disciplinary management.
Source: Journal of Stroke and Cerebrovascular Diseases - September 25, 2020 Category: Neurology Authors: Dr. P.V. Sripadma, Dr. Ashish Rai, Dr. Chetan Wadhwa Tags: Case Report Source Type: research

Cerebral venous thrombosis in patients with COVID-19 infection: a case series and systematic review
: There has been increasing reports associating the coronavirus disease 2019 (COVID-19) with thromboembolic phenomenon including ischemic strokes and venous thromboembolism. Cerebral venous thrombosis (CVT) is a rare neurovascular emergency that has been observed in some COVID-19 patients, yet much remains to be learnt of its underlying pathophysiology.
Source: Journal of Stroke and Cerebrovascular Diseases - October 5, 2020 Category: Neurology Authors: Tian Ming Tu, Claire Goh, Ying Kiat Tan, Aloysius ST Leow, Yu Zhi Pang, Jaime Chien, Humaira Shafi, Bernard PL Chan, Andrew Hui, Jasmine Koh, Benjamin YQ Tan, N. Thirugnanam Umapathi, Leonard LL Yeo Source Type: research

Cerebral Venous Sinus Thromboses in Patients with SARS-CoV-2 Infection: Three Cases and a Review of the Literature
: Early studies suggest that acute cerebrovascular events may be common in patients with coronavirus disease 2019 (COVID-19) and may be associated with a high mortality rate. Most cerebrovascular events described have been ischemic strokes, but both intracerebral hemorrhage and rarely cerebral venous sinus thrombosis (CVST) have also been reported. The diagnosis of CVST can be elusive, with wide-ranging and nonspecific presenting symptoms that can include headache or altered sensorium alone.
Source: Journal of Stroke and Cerebrovascular Diseases - October 19, 2020 Category: Neurology Authors: Felix Nwajei, Pria Anand, Mohamad Abdalkader, Vanesa C. Andreu Arasa, Hugo J. Aparicio, Siavash Behbahani, Gioacchino Curiale, Ali Daneshmand, Hormuzdiyar Dasenbrock, Thomas Mayo, Asim Mian, Thanh Nguyen, Charlene Ong, J. Rafael Romero, Osamu Sakai, Court Source Type: research

Covid-19 and major organ thromboembolism: manifestations in neurovascular and cardiovascular systems.
COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been shown to cause multisystemic damage. We undertook a systematic literature review and comprehensive analysis of a total of 55 articles on arterial and venous thromboembolism in COVID-19 and articles on previous pandemics with respect to thromboembolism and compared the similarities and differences between them. The presence of thrombosis in multiple organ systems points to thromboembolism being an integral component in the pathogenesis of this disease.
Source: Journal of Stroke and Cerebrovascular Diseases - October 24, 2020 Category: Neurology Authors: Presaad Pillai, Joyce Pauline Joseph, Nurul Huda Mohamad Fadzillah, Masliza Mahmod Tags: Review Article Source Type: research

Acute Cerebrovascular Disorders and Vasculopathies associated with Significant Mortality in SARS-CoV-2 patients admitted to the Intensive Care Unit in The New York Epicenter
We present a case series of consecutive COVID-19 patients with cerebrovascular disease treated at our institution including 3 cases of cerebral artery dissection including subarachnoid hemorrhage. Knowledge of the varied presentations including dissections will help treating clinicians at the bedside monitor and manage these complications preemptively.
Source: Journal of Stroke and Cerebrovascular Diseases - October 31, 2020 Category: Neurology Authors: Fawaz Al-Mufti, Christian Becker, Haris Kamal, Hussein Alshammari, Vincent Dodson, Rolla Nuoman, Katarina Dakay, Jared Coper, Edwin Gulko, Gurmeen Kaur, Ramandeep Sahni, Corey Scurlock, Stephan A. Mayer, Chirag D. Gandhi Source Type: research

Intracranial hemorrhage in hospitalized SARS-CoV-2 Patients: A Case Series
The SARS-CoV-2 virus causing Coronavirus Disease 2019 (COVID-19) is a global pandemic with almost 30 million confirmed worldwide cases. Prothrombotic complications arising from those affected with severe symptoms have been reported in various medical journals. Currently, clinical trials are underway to address the questions regarding anticoagulation dosing strategies to prevent thrombosis for these critically ill patients. However, given the increasing use of therapeutic anticoagulation in patients admitted with COVID-19 to curtail this prothrombotic state, our institution has witnessed six cases of devastating intracrania...
Source: Journal of Stroke and Cerebrovascular Diseases - October 31, 2020 Category: Neurology Authors: Fady Mousa-Ibrahim, Stephanie Berg, Oluwatobi Odetola, Michael Teitcher, Sean Ruland Source Type: research

COVID-19 Respiratory Illness and Subsequent Cerebrovascular Events, the Initial Iranian Experience
Coronavirus disease 2019 (COVID-19) infection has rapidly spread across the world, currently affecting more than 39 million people, leading to major societal, economical and health care system distruptions.1 Older adults and those with vascular co-morbidities are disproportionately affected.2,3 More than one third of patients who required intensive care unit admission had at least one underlying vascular risk factor.4 In addition to respiratory symptoms, COVID-19 infection can also lead to hematological and cardiac complications.
Source: Journal of Stroke and Cerebrovascular Diseases - November 6, 2020 Category: Neurology Authors: Behnam Sabayan, Mohsen Moghadami, Farhad Assarzadegan, Sahar Hojjat-Anasri Komachali, Leila Poordast, Zabihollah Babaeepour, Seyed Amir Ebrahimzadeh, Ava Hamidi, Zeinab Hasheminejad, Elahe Mohammadi-Vosough, Hamid Reza Mirkarimi, Sepideh Paybast, Nasrin R Source Type: research

Pages: 1  2  3  4  5  6